Clinical Trials Browser

Terminated × Breast Neoplasms × Neoadjuvant Therapy × Clear all

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Phase 2 Terminated

3 enrolled 6 charts

Breast Neoplasms

NCT01147016 2023-04-27

Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery

Phase 2 Terminated

8 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00740961 2020-07-27

Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms

NCT02532400 2020-03-11

COMPETE

Phase 3 Terminated

Breast Neoplasms

NCT00503841 2019-04-30

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Phase NA Terminated

44 enrolled 3 charts

Breast Neoplasms

NCT00080626 2019-03-21

Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00088829 2018-07-11

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer

Phase 2 Terminated

22 enrolled 3 charts

Breast Neoplasms

NCT01776008 2018-05-08

Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer

Phase 2 Terminated

16 enrolled 5 charts

Breast Neoplasms

NCT00524459 2014-08-29

Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase 2 Terminated

6 enrolled 5 charts

Breast Neoplasms

NCT00343512 2012-04-27

Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Phase 2 Terminated

34 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms